FDA Emergency Use Authorization permits asymptomatic, non-prescription, over-the-counter self use for people with or without symptoms The BinaxNOW COVID-19 Self Test is identical to the ...
ABBOTT PARK, Ill., Jan. 26, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for two new uses of its Panbio™ COVID-19 Ag Rapid Test Device for the detection of the ...
Abbott Laboratories in August won Food and Drug Administration emergency clearance for its portable test for the coronavirus strain Covid-19 that sells for just $5 and allow for “frequent mass testing ...
Good news: In the wake of research suggesting that taking a rapid at-home COVID test may not catch your omicron infection, a new real-world study found that the Abbott BinaxNOW rapid at-home test is ...
Due to an increase in the campus COVID-19 positivity rate, the University began requiring students to complete one Abbott rapid antigen test in addition to the typical Color test each week. According ...
Abbott Laboratories said Wednesday it received federal emergency use authorization for its in-home rapid COVID-19 test, with results available in 15 minutes. The north suburban-based medical device ...
Shortly after Abbott completed its delivery of 150 million rapid antigen tests to the federal government for widespread distribution against the COVID-19 pandemic, researchers at the Centers for ...
NORTH CHICAGO, IL — As demand for COVID-19 testing skyrockets during the omicron surge, officials at Abbott Labs hope to soon be making twice as many BinaxNOW rapid test kits as the company produced ...
ABBOTT PARK, Ill., March 31, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback